Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1CNS 1

Conditions

Melanoma 33Neoplasm Metastasis 3Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Sarcoma 1Recurrence 1Oligodendroglioma 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Brain Neoplasms 1Astrocytoma 1

Interventions

cediranib 1carboxyamido-triazole 1Vinblastine 1Thalidomide 1Paclitaxel 1Introns 1Immunologic Techniques 1Fentanyl 1Docetaxel 1Dacarbazine 1Cisplatin 1Antimony Sodium Gluconate 190Y-octreotide, DOTA-Tyr(3)- 14-boronophenylalanine-fructose 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Introns × Dermatologic × Clear all
NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡